SANIGEN Co., Ltd. Logo

SANIGEN Co., Ltd.

Provides food safety solutions and genetic diagnostics for the entire food industry.

188260 | KO

Overview

Corporate Details

ISIN(s):
KR7188260004
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 흥안대로427번길 16, 411호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SANIGEN Co., Ltd. is a food safety and sanitation company that provides total solutions for the food industry, encompassing manufacturing, distribution, and sales. The company specializes in developing and manufacturing advanced diagnostic products based on microbial genetic analysis technologies, including Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS). Founded in 2005, Sanigen delivers innovative technologies and differentiated services aimed at establishing hygienic manufacturing environments and ensuring food safety, with a mission to protect human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Regulatory News Service
거래처와의거래중단
Korean 7.2 KB
2025-09-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.7 KB
2025-08-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 131.3 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.6 MB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.4 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.0 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.2 KB
2025-03-06 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 100.2 KB
2025-02-13 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2025-02-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all SANIGEN Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANIGEN Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANIGEN Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.